7th Sep 2006 10:54
Oxford Biomedica PLC07 September 2006 Oxford BioMedica plc ("the Company") Interest in share options Oxford BioMedica (OXB:L). The Company today announced that, as part of a grantof share options to a number of eligible employees, it had granted 209,000options over 1p ordinary shares under the Oxford BioMedica 1996 (No.1) shareoption scheme on 6 September 2006 to Dr Michael McDonald, Chief Medical Officerwho joined the board of the Company in February 2006, and 172,531 to SharonWood, who is an employee of Oxford BioMedica and is the wife of Andrew Wood,Chief Financial Officer and Company Secretary. It is the Company's policy to award share options to all UK employees, followingthe announcement of full-year or half-year results. The exercise price for theoptions is 31.0 pence per share. The options become exercisable three years fromthe date of grant and will remain exercisable up to seven years from the date ofgrant. The options granted to Dr McDonald are subject to a performancecondition: the options will only be exercisable if at the time of exercise, orfor at least 12 months in the three years before exercise, the percentageincrease in Oxford BioMedica's Total Shareholder Return exceeds the percentageincrease in the FTSE TechMark Mediscience index since the date of grant of theoption. Following the grant of these options, Dr Michael McDonald has an interest inoptions over a total of 1,347,500 of the Company's shares, and Sharon Wood hasan interest in options over 345,062 shares. Andrew Wood Company Secretary, Oxford BioMedica plc 7 September 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Oxford Biomedica